-
1
-
-
0026446492
-
Melton LJ III. Hip fractures in the elderly: a worldwide projection
-
Cooper C., and Campion G. Melton LJ III. Hip fractures in the elderly: a worldwide projection. Osteoporosis Int 2 (1992) 285-289
-
(1992)
Osteoporosis Int
, vol.2
, pp. 285-289
-
-
Cooper, C.1
Campion, G.2
-
2
-
-
23844436308
-
Aging bones: osteoporosis and injurious falls in the oldest women
-
Heffernan J.D., and Messinger-Rapport B.J. Aging bones: osteoporosis and injurious falls in the oldest women. Clin Rev Bone and Miner Metab 3 2 (2005) 157-173
-
(2005)
Clin Rev Bone and Miner Metab
, vol.3
, Issue.2
, pp. 157-173
-
-
Heffernan, J.D.1
Messinger-Rapport, B.J.2
-
3
-
-
0029981702
-
Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population
-
Miller P.D., Bonnick S.L., and Rosen C.J. Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population. Calcif Tissue Int 58 (1996) 207-214
-
(1996)
Calcif Tissue Int
, vol.58
, pp. 207-214
-
-
Miller, P.D.1
Bonnick, S.L.2
Rosen, C.J.3
-
4
-
-
34147123172
-
Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences
-
Boonen S. Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: similarities and differences. Bone 40 (2007) S26-S31
-
(2007)
Bone
, vol.40
-
-
Boonen, S.1
-
5
-
-
9144233479
-
The effects of strontium ranelate on risk of vertebral fracture in women with postmenopausal osteoporosis
-
Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
-
(2004)
N Engl J Med
, vol.350
, pp. 459-468
-
-
Meunier, P.J.1
Roux, C.2
Seeman, E.3
-
6
-
-
21044447888
-
Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: TROPOS study
-
Reginster J., Seeman E., Vernejoul M., et al. Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: TROPOS study. J Clin Endocrinol Metab 90 (2005) 2816-2822
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 2816-2822
-
-
Reginster, J.1
Seeman, E.2
Vernejoul, M.3
-
7
-
-
0033016402
-
A high incidence of vertebral fracture in women with breast cancer
-
Kanis J.A., McCloskey E.V., Powles T., Paterson A.H., Ashley S., and Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79 7-8 (1999) 1179-1181
-
(1999)
Br J Cancer
, vol.79
, Issue.7-8
, pp. 1179-1181
-
-
Kanis, J.A.1
McCloskey, E.V.2
Powles, T.3
Paterson, A.H.4
Ashley, S.5
Spector, T.6
-
8
-
-
14844292675
-
Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study
-
Chen Z., Maricic M., Bassford T.L., et al. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 165 6 (2005) 552-558
-
(2005)
Arch Intern Med
, vol.165
, Issue.6
, pp. 552-558
-
-
Chen, Z.1
Maricic, M.2
Bassford, T.L.3
-
9
-
-
24944500572
-
Bone loss and the aromatase inhibitors
-
Lester J., and Coleman R. Bone loss and the aromatase inhibitors. Br J Cancer 93 suppl 1 (2005) S16-S22
-
(2005)
Br J Cancer
, vol.93
, Issue.SUPPL. 1
-
-
Lester, J.1
Coleman, R.2
-
10
-
-
20044382779
-
American Society of Clinical Oncology Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004
-
Winer E.P., Hudis C., Burstein H.J., et al. American Society of Clinical Oncology Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23 23 (2005) 619-629
-
(2005)
J Clin Oncol
, vol.23
, Issue.23
, pp. 619-629
-
-
Winer, E.P.1
Hudis, C.2
Burstein, H.J.3
-
11
-
-
0642342669
-
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
-
Hillner B., Ingle J., Chlebowski R., et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21 21 (2003) 4042-4057
-
(2003)
J Clin Oncol
, vol.21
, Issue.21
, pp. 4042-4057
-
-
Hillner, B.1
Ingle, J.2
Chlebowski, R.3
-
13
-
-
1642391691
-
The Writing Group for the ISCD Position Development Conference. Position statement. Introduction, methods and participants
-
The Writing Group for the ISCD Position Development Conference. Position statement. Introduction, methods and participants. J Clin Densitom 7 1 (2004) 13-15
-
(2004)
J Clin Densitom
, vol.7
, Issue.1
, pp. 13-15
-
-
-
14
-
-
2942654145
-
-
National Osteoporosis Society NOS, Bath
-
Fogelman I., Adams J., McCrea J., Steel S.A., and Blake G.M. Position statement on the reporting of dual energy x-ray Absorptiometry (DXA) bone mineral density scans (2002), National Osteoporosis Society. (www.nos.org.uk) NOS, Bath
-
(2002)
Position statement on the reporting of dual energy x-ray Absorptiometry (DXA) bone mineral density scans
-
-
Fogelman, I.1
Adams, J.2
McCrea, J.3
Steel, S.A.4
Blake, G.M.5
-
15
-
-
0034760560
-
Prediction equations to estimate glomerular filtration rate: an update
-
Manjunath G., Sarnak M.J., and Levey A.S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertension 10 (2001) 785-792
-
(2001)
Curr Opin Nephrol Hypertension
, vol.10
, pp. 785-792
-
-
Manjunath, G.1
Sarnak, M.J.2
Levey, A.S.3
-
16
-
-
0026585852
-
Effects of tamoxifen on bone mineral density in post-menopausal women with breast cancer
-
Love R.R., Mazess R.B., Barden H.S., et al. Effects of tamoxifen on bone mineral density in post-menopausal women with breast cancer. N Engl J Med 326 (1992) 852-856
-
(1992)
N Engl J Med
, vol.326
, pp. 852-856
-
-
Love, R.R.1
Mazess, R.B.2
Barden, H.S.3
-
17
-
-
0028060362
-
The diagnosis of osteoporosis
-
Kanis J.A., Melton III L.J., Christiansen C., Johnston C.C., and Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 8 (1994) 1137-1141
-
(1994)
J Bone Miner Res
, vol.8
, pp. 1137-1141
-
-
Kanis, J.A.1
Melton III, L.J.2
Christiansen, C.3
Johnston, C.C.4
Khaltaev, N.5
-
18
-
-
0029858793
-
Bone Mineral Density and risk of breast cancer in older women: the study ofosteoporotic fractures. Study of osteoporotic fractures research group
-
Cauley J.A., Lucas F.L., Kuller J.H., et al. Bone Mineral Density and risk of breast cancer in older women: the study ofosteoporotic fractures. Study of osteoporotic fractures research group. JAMA 276 17 (1996) 1404-1408
-
(1996)
JAMA
, vol.276
, Issue.17
, pp. 1404-1408
-
-
Cauley, J.A.1
Lucas, F.L.2
Kuller, J.H.3
-
20
-
-
33746455931
-
The ATAC trialist's Group. Effect of an AI on BMD and bone turnover markers: 2-year results of the anastrozole, Tamoxifen alone or in combination (ATAC) trial
-
Eastell R., Hannon R.A., Cuzick J., Dowsett M., Clack G., and Adams J.E. The ATAC trialist's Group. Effect of an AI on BMD and bone turnover markers: 2-year results of the anastrozole, Tamoxifen alone or in combination (ATAC) trial. J Bone Miner Res 21 8 (2006) 1215-1223
-
(2006)
J Bone Miner Res
, vol.21
, Issue.8
, pp. 1215-1223
-
-
Eastell, R.1
Hannon, R.A.2
Cuzick, J.3
Dowsett, M.4
Clack, G.5
Adams, J.E.6
-
21
-
-
0141527583
-
Is the paradigm shifting?
-
Heaney R.P. Is the paradigm shifting?. Bone 33 4 (2003) 457-465
-
(2003)
Bone
, vol.33
, Issue.4
, pp. 457-465
-
-
Heaney, R.P.1
-
22
-
-
27444437924
-
Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study
-
Sornay-Rendu E., Munoz F., Duboeuf F., and Delmas P.D. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. J Bone Miner Res 20 11 (2005) 1929-1935
-
(2005)
J Bone Miner Res
, vol.20
, Issue.11
, pp. 1929-1935
-
-
Sornay-Rendu, E.1
Munoz, F.2
Duboeuf, F.3
Delmas, P.D.4
-
23
-
-
0032835427
-
Fracture risk in primary hyperparathyroidism
-
Khosla S., and Melton J. Fracture risk in primary hyperparathyroidism. J Bone Miner Res 14 10 (1999) 1700-1707
-
(1999)
J Bone Miner Res
, vol.14
, Issue.10
, pp. 1700-1707
-
-
Khosla, S.1
Melton, J.2
-
24
-
-
33845807308
-
Primary hyperparathyroidism is common in postmenopausal women with forearm fracture and low bone mineral density
-
Bergstrom I., Landgren B.M., and Freyschuss B. Primary hyperparathyroidism is common in postmenopausal women with forearm fracture and low bone mineral density. Acta Obstet Gynecol Scand 86 1 (2007) 61-64
-
(2007)
Acta Obstet Gynecol Scand
, vol.86
, Issue.1
, pp. 61-64
-
-
Bergstrom, I.1
Landgren, B.M.2
Freyschuss, B.3
-
25
-
-
0029928837
-
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
-
Garnero P., Sornay-Rendu E., Chapuy M.-C., and Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11 3 (1996) 337-349
-
(1996)
J Bone Miner Res
, vol.11
, Issue.3
, pp. 337-349
-
-
Garnero, P.1
Sornay-Rendu, E.2
Chapuy, M.-C.3
Delmas, P.D.4
-
26
-
-
0038059244
-
Vitamin D in preventive medicine: are we ignoring the evidence?
-
Zitterman A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br J Nutrition 89 (2003) 552-572
-
(2003)
Br J Nutrition
, vol.89
, pp. 552-572
-
-
Zitterman, A.1
-
27
-
-
33750522464
-
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomized placebo-controlled study
-
Geisler J., Lønning P.E., Kraq L.E., et al. Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomized placebo-controlled study. Eur J Cancer 42 (2006) 2968-2975
-
(2006)
Eur J Cancer
, vol.42
, pp. 2968-2975
-
-
Geisler, J.1
Lønning, P.E.2
Kraq, L.E.3
|